News from drug discoveries

Biotech Stocks Take A Tariffs Hit. But Drugs Are Exempt — For Now.

Pharma tariff relief likely short-lived with sector-specific duties on the horizon

'organogold' complexes might open exciting avenues for fighting cancer

Researchers develop new way to match young cancer patients with the right drugs

Why Shares of Axsome Therapeutics Slumped Today

Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up

One dose of experimental drug nearly wipes out stealthy cholesterol in 'remarkable' trial

EDITORIAL: It’s time to talk law and order

New blood pressure drug helps people with uncontrolled hypertension in trial

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

New drug for lower back pain could be ‘a gamechanger’

Novel class of zwitterionic phospholipids enhances mRNA delivery

Arcutis Biotherapeutics (ARQT) stock soars on hopes to eliminate eczema and psoriasis trade-off

Eli Lilly Alzheimer’s drug Kisunla fails to get EU backing

Exelixis’ cabozantinib approval ‘certainly positive,’ says Citi

Nanocomposite hydrogel adapts to multiple stimuli for targeted drug release

1 Growth Stock Down 40% to Buy and Hold Forever

Is Merck Stock a Bargain Buy?

‘This is our child’s life’: B.C. family gets small extension for crucial drug funding | Globalnews.ca